All In Biotech

Drug Trial Radar · NCT04649359

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

MAGNETISMM-3 AN OPEN-LABEL, MULTICENTER, NON-RANDOMIZED PHASE 2 STUDY OF ELRANATAMAB (PF-06863135) MONOTHERAPY IN PARTICIPANTS WITH MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY DRUG AND ONE ANTI-CD38 ANTIBODY

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

187

Actual

Start

Feb 2, 2021

Primary completion

Jun 17, 2022

Study completion Aug 25, 2026

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Dec 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate whether single-agent Elranatamab (PF-06863135) can provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding of Elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.

Conditions

  • Multiple Myeloma

Interventions

  • Elranatamab (PF-06863135)Drug

    BCMA-CD3 bispecific antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR) by Blinded Independent Central Review (BICR) as Per International Myeloma Working Group (IMWG) CriteriaTime frame: From date of first dose until confirmed disease progression, death, start of new anticancer therapy, whichever occurred first (up to approximately 16 months)

Locations

78 sites in 10 countries. Site status is shown where the registry gives one.

  • Beverly Hills Cancer Center

    Beverly Hills, California

  • Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California

  • The Regents of the University of California

    Irvine, California

  • UCLA Hematology/Oncology Clinic

    Los Angeles, California

  • UCLA Ronald Reagan Medical Center

    Los Angeles, California

  • UC Irvine Health - Chao Family Comprehensive Cancer Center

    Orange, California

  • Baptist Hospital of Miami

    Miami, Florida

  • Miami Cancer Institute

    Miami, Florida

  • Winship Cancer Institute @ Emory University Hospital Midtown

    Atlanta, Georgia

  • Emory University Hospital

    Atlanta, Georgia

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia

  • Blood and Marrow Transplant Group of Georgia

    Atlanta, Georgia

  • Emory Saint Joseph's Hospital

    Atlanta, Georgia

  • Northside Hospital

    Atlanta, Georgia

  • Northwestern Medical Group

    Chicago, Illinois

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Loyola University Chicago performing research at Loyola University Medical Center

    Maywood, Illinois

  • Indiana Blood and Marrow Transplantation

    Indianapolis, Indiana

  • University of Iowa - Holden Comprehensive Cancer Center

    Iowa City, Iowa

  • Norton Cancer Institute, St. Matthews Campus

    Louisville, Kentucky

  • Norton Women's and Children's Hospital

    Louisville, Kentucky

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • John Theurer Cancer Center at Hackensack University Medical Center

    Hackensack, New Jersey

  • Roswell Park Cancer Institute

    Buffalo, New York

  • Memorial Sloan Kettering Cancer Center-Investigational Drug Service Pharmacy

    Long Island City, New York

  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).

    New York, New York

  • Weill Cornell Medical College - New York Presbyterian Hospital

    New York, New York

  • Weill Cornell Medical College - New York-Presbyterian Hospital

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Weill Cornell Medical College - New York Presbyterian Hospital

    New York, New York

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • St. Francis Hospital

    Greenville, South Carolina

  • Saint Francis Hospital Cancer Center

    Greenville, South Carolina

  • St Francis Eastside

    Greenville, South Carolina

  • Baylor University Medical Center

    Dallas, Texas

  • Epworth Healthcare

    East Melbourne, Victoria, Australia

  • St Vincent's Hospital (Melbourne)

    Fitzroy, Victoria, Australia

  • The Alfred

    Melbourne, Victoria, Australia

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.